Portugal's Directorate-General of Health. Its National Programme for Oncological Diseases wrote the national cancer strategy to 2030 and monitors the screening programmes, and its standards set the HPV vaccination schedule.
The Direção-Geral da Saúde (DGS) issues standards (normas) addressed to the whole health system, among them those of the national vaccination programme. Despacho 13227/2023, published on 27 December 2023, records that the Estratégia Nacional de Luta contra o Cancro, horizonte 2030 was prepared by the DGS through its Programa Nacional para as Doenças Oncológicas (PNDO), with other national programmes, the NHS Executive Board and the Portuguese Environment Agency, after a public consultation from 30 June to 29 July 2022; the strategy is coordinated by an executive committee led by the PNDO's director. The strategy has four pillars, prevention, early detection, diagnosis and treatment, and survivors, and its targets include formalising an Oncology Referral Network by 2026, publishing the time taken to decide reimbursement of innovative cancer medicines by 2025, and doubling the number of cancer clinical trials under way by 2027.
The PNDO's monitoring of 2022 population screening, published in 2023, is the source the OECD's 2025 profile uses for screening coverage. The directorate's Norma 002/2026 of 8 April 2026, signed by the Director-General Rita Sá Machado, sets the national HPV vaccination schedule: two doses of the nine-valent vaccine at age 10 for both sexes, catch-up to age 18 for both sexes and to 27 for women, and a phased catch-up for men born from 2000.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-11-19.
Matched to Direcção-Geral da Saúde, including child institutions. 2 works · 14 citations · 100% open access · 0% clinical trials · 0% reviews.
| Work | Journal | Year | Citations |
|---|---|---|---|
| Promoting physical activity through supervised vs motivational behavior change interventions in breast cancer survivors on aromatase inhibitors (PAC-WOMAN): protocol for a 3-arm pragmatic randomized controlled trial 10.1186/s12885-023-11137-1 · open access | BMC Cancer | 2023 | 14 |
| Exercício físico para pessoas com doença crónica : Exercício físico para pessoas com doença oncológica book · · open access | Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) | 2022 | 0 |
Shares Portuguese National Health Service (Serviço Nacional de Saúde), Portuguese National Cancer Registry (Registo Oncológico Nacional).
Shares Portuguese National Health Service (Serviço Nacional de Saúde), Portuguese National Cancer Registry (Registo Oncológico Nacional).
Shares Portuguese National Health Service (Serviço Nacional de Saúde), Portuguese National Cancer Registry (Registo Oncológico Nacional), Colorectal cancer.
Shares Portuguese National Health Service (Serviço Nacional de Saúde), Portuguese National Cancer Registry (Registo Oncológico Nacional), Colorectal cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/